Tenney, Alan P.
Di Gioia, Silvio Alessandro http://orcid.org/0000-0002-7235-5682
Webb, Bryn D.
Chan, Wai-Man http://orcid.org/0000-0002-2888-4739
de Boer, Elke http://orcid.org/0000-0002-7022-577X
Garnai, Sarah J. http://orcid.org/0000-0002-0283-5437
Barry, Brenda J.
Ray, Tammy
Kosicki, Michael
Robson, Caroline D. http://orcid.org/0000-0001-5592-249X
Zhang, Zhongyang http://orcid.org/0000-0002-2521-3884
Collins, Thomas E.
Gelber, Alon
Pratt, Brandon M. http://orcid.org/0000-0002-1509-7509
Fujiwara, Yuko
Varshney, Arushi http://orcid.org/0000-0001-9177-9707
Lek, Monkol http://orcid.org/0000-0003-1227-6293
Warburton, Peter E.
Van Ryzin, Carol
Lehky, Tanya J.
Zalewski, Christopher
King, Kelly A.
Brewer, Carmen C.
Thurm, Audrey
Snow, Joseph
Facio, Flavia M.
Narisu, Narisu http://orcid.org/0000-0002-8483-1156
Bonnycastle, Lori L.
Swift, Amy
Chines, Peter S.
Bell, Jessica L. http://orcid.org/0000-0001-9563-0125
Mohan, Suresh http://orcid.org/0000-0002-4797-9565
Whitman, Mary C. http://orcid.org/0000-0001-6297-7499
Staffieri, Sandra E. http://orcid.org/0000-0003-3131-9359
Elder, James E.
Demer, Joseph L. http://orcid.org/0000-0001-9662-5352
Torres, Alcy
Rachid, Elza http://orcid.org/0000-0003-3756-0872
Al-Haddad, Christiane
Boustany, Rose-Mary http://orcid.org/0000-0002-2066-0079
Mackey, David A.
Brady, Angela F.
Fenollar-Cortés, María
Fradin, Melanie
Kleefstra, Tjitske
Padberg, George W.
Raskin, Salmo http://orcid.org/0000-0002-7191-0592
Sato, Mario Teruo
Orkin, Stuart H. http://orcid.org/0000-0002-0313-152X
Parker, Stephen C. J. http://orcid.org/0000-0001-8122-0117
Hadlock, Tessa A.
Vissers, Lisenka E. L. M. http://orcid.org/0000-0001-6470-5497
van Bokhoven, Hans http://orcid.org/0000-0002-2153-9254
Jabs, Ethylin Wang http://orcid.org/0000-0001-8983-5466
Collins, Francis S.
Pennacchio, Len A. http://orcid.org/0000-0002-8748-3732
Manoli, Irini http://orcid.org/0000-0003-1543-2941
Engle, Elizabeth C. http://orcid.org/0000-0001-8194-7738
Funding for this research was provided by:
DH | NIHR | Efficacy and Mechanism Evaluation Programme (U01HD079068)
Article History
Received: 17 March 2021
Accepted: 10 May 2023
First Online: 29 June 2023
Competing interests
: S.A.D.G. is a Regeneron Pharmaceuticals employee and stockholder.